BRIEF-Redhill Biopharma receives additional U.S. Patent covering RHB-105

July 21 (Reuters) – * Redhill Biopharma gets additional U.S. patent covering
RHB-105 ahead of confirmatory stage III study for H. Pylori
infection

* Gotten notice of allowance for extra U.S. Patent
covering RHB-105, expected to be valid up until 2034 once granted

Source text for Eikon:

( Bengaluru Newsroom; +1 646 223 8780).

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *